SCHEMBL627503

SCHEMBL627503

O=C(O)Cc1cc(-c2ccc(Cl)c(C(F)(F)F)c2)no1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 10/20 0.48
CYP1A2 P05177 1/20 0.44
PPARD Q03181 1/20 0.44
RXRA P19793 1/20 0.43
RXRB P28702 1/20 0.43
RXRG P48443 1/20 0.43
FAAH O00519 1/20 0.42
POLB P06746 1/20 0.41
CASP3 P42574 1/20 0.40
P2RX7 Q99572 1/20 0.40
JAK2 O60674 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KMO O15229 1/20 0.40
P2RY14 Q15391 1/20 0.40
GRIN2B Q13224 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3221069 0.84 L3MBTL1 (0.48) NOTUMPOLBJAK2ALDH1A1HTT
SCHEMBL10029580 0.82 POLB (0.47) NOTUMCYP1A2PPARDPOLBJAK2
SCHEMBL27729677 0.78 NOTUM (0.67) NOTUMCYP1A2POLBJAK2ALDH1A1
SCHEMBL27788409 0.75 NOTUM (0.65) NOTUMCYP1A2POLBSMN1; SMN2L3MBTL1
SCHEMBL25218594 0.74 NOTUM (0.50) NOTUMCYP1A2PPARDPOLBJAK2
SCHEMBL4142743 0.73 NOTUM (0.67) NOTUMCYP1A2POLBSMN1; SMN2L3MBTL1
SCHEMBL27729720 0.73 MEN1 (0.53) NOTUMCYP1A2PPARDPOLBCASP3
SCHEMBL628055 0.72 LMNA (0.60) NOTUMALDH1A1HTTSMN1; SMN2
SCHEMBL28825183 0.72 SMN1; SMN2 (0.38) NOTUMCYP1A2POLBJAK2ALDH1A1
SCHEMBL1590516 0.70 RXRA (0.55) PPARDRXRARXRBRXRGFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120077854-A1 COMPOSITIONS AND METHODS FOR MODULATING RETINOL BINDING TO RETINOL BINDING PROTEIN 4 (RBP4) IRM LLC (BM) 2012-03-29 US disclosed
EP-2419412-A1 COMPOSITIONS AND METHODS FOR MODULATING RETINOL BINDING TO RETINOL BINDING PROTEIN 4 (RBP4) IRM LLC (BM) 2012-02-22 EP disclosed
WO-2010120741-A1 COMPOSITIONS AND METHODS FOR MODULATING RETINOL BINDING TO RETINOL BINDING PROTEIN 4 (RBP4) IRM LLC (US) 2010-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077854-A1 COMPOSITIONS AND METHODS FOR MODULATING RETINOL BINDING TO RETINOL BINDING PROTEIN 4 (RBP4) RBP4, RBP1, FABP4 NOTUM 3362/4885CYP1A2 3111/4885PPARD 917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.